Personalized Healthcare And Automation Will Unlock Future Markets

Published
09 Feb 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$8.99
44.4% undervalued intrinsic discount
08 Aug
US$5.00
Loading
1Y
-8.8%
7D
-1.4%

Author's Valuation

US$9.0

44.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on06 May 25
Fair value Decreased 0.64%

Shared on01 May 25
Fair value Decreased 0.67%

AnalystConsensusTarget has decreased profit margin from 6.3% to 5.7% and increased future PE multiple from 29.4x to 32.9x.

Shared on23 Apr 25
Fair value Decreased 10%

Shared on17 Apr 25
Fair value Decreased 4.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 1.63%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 3.47%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 1.51%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 1.10%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 9.01%

AnalystConsensusTarget has decreased revenue growth from 8.6% to 6.3%, decreased profit margin from 6.8% to 6.0% and increased future PE multiple from 29.5x to 36.6x.